Aspen Pharmacare signs voluntary licensing deal with MSD for once-monthly HIV prevention pill MK-8527PUBT·2 days ago, 07:13 AMMRK+0.45%
First Trust Advisors LP Acquires 1,305 Shares of Eli Lilly and Company $LLYMarket Beat·2 days ago, 02:52 AMLLY+0.86%ELIL+1.89%
Cardiovascular disease biotech Scribe Therapeutics prices upsized IPO at $15, the high end of the rangeRenaissanceCapital·2 days ago, 07:21 AMSNY-2.00%LLY+0.86%
Genmab, AbbVie clarify primary endpoints in Phase 3 EPCORE DLBCL-1 trialPUBT·2 days ago, 03:00 PMGMAB-1.03%ABBV+0.95%
FDA panel approves expanded use of peptides in compounding pharmacies, raising concerns about prescription surge in billion-dollar industry.Unusual Whales·1 day ago, 05:24 PMIXJ+0.60%BBH-0.23%
Lilly Targets Early 2027 Filing for Next Obesity DrugGuruFocus·2 days ago, 12:13 PMLLY+0.86%LLYZ0.00%
Eli Lilly's Retatrutide Meets Primary Endpoint In Phase 3 TRIUMPH-2 And TRIUMPH-3 Trialsrttnews·Jul 23 at 06:15 AMLLY+0.86%ELIS0.00%
J&J Says TECVAYLI+TALVEY Cuts Risk Of Disease Progression Or Death By 89% In Multiple Myeloma Trialrttnews·Jul 23 at 08:09 AMJNJ+1.59%
Johnson & Johnson posts press release on MonumenTAL-6 multiple myeloma trial resultsPUBT·Jul 23 at 07:30 AMJNJ+1.59%
Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trialsCNBC·Jul 23 at 05:45 AMLLY+0.86%ELIS0.00%
Public Employees Retirement System of Ohio Has $125.54 Million Stock Position in Merck & Co., Inc. $MRKMarket Beat·2 days ago, 05:34 AMMRK+0.45%
HBM Healthcare swings to CHF 238 million Q1 FY27 profit; NAV per share rises 13%PUBT·2 days ago, 11:40 PMLLY+0.86%ELIS0.00%
Johnson & Johnson's Ottava gets FDA approval; Goldman launches private-company investing platformCoinLive·Jul 22 at 02:05 PMJNJ+1.59%GS-D+0.31%
Agilent wins EU approval for PD-L1 IHC 22C3 test in ovarian cancer patientsPUBT·Jul 23 at 07:04 AMA-0.84%MRK+0.45%
Bank of Nova Scotia Cuts Stock Position in AbbVie Inc. $ABBVMarket Beat·2 days ago, 02:30 AMABBV+0.95%
